Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

UHS vs HCA vs THC vs CYH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
UHS
Universal Health Services, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$10.55B
5Y Perf.+59.8%
HCA
HCA Healthcare, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$96.01B
5Y Perf.+301.7%
THC
Tenet Healthcare Corporation

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$17.04B
5Y Perf.+793.9%
CYH
Community Health Systems, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$404M
5Y Perf.-8.9%

UHS vs HCA vs THC vs CYH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
UHS logoUHS
HCA logoHCA
THC logoTHC
CYH logoCYH
IndustryMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care FacilitiesMedical - Care Facilities
Market Cap$10.55B$96.01B$17.04B$404M
Revenue (TTM)$17.76B$75.60B$21.45B$21.48B
Net Income (TTM)$1.52B$6.78B$1.70B$-88M
Gross Margin67.6%41.5%42.8%53.7%
Operating Margin11.5%15.8%16.1%-39.8%
Forward P/E7.2x14.2x11.0x0.8x
Total Debt$5.51B$50.20B$13.17B$11.58B
Cash & Equiv.$138M$1.04B$2.88B$260M

UHS vs HCA vs THC vs CYHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

UHS
HCA
THC
CYH
StockMay 20May 26Return
Universal Health Se… (UHS)100159.8+59.8%
HCA Healthcare, Inc. (HCA)100401.7+301.7%
Tenet Healthcare Co… (THC)100893.9+793.9%
Community Health Sy… (CYH)10091.1-8.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: UHS vs HCA vs THC vs CYH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HCA leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Universal Health Services, Inc. is the stronger pick specifically for growth and revenue expansion. THC and CYH also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
UHS
Universal Health Services, Inc.
The Growth Play

UHS is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.

  • Rev growth 9.7%, EPS growth 37.3%, 3Y rev CAGR 9.0%
  • Lower volatility, beta 0.60, Low D/E 74.3%, current ratio 1.05x
  • 9.7% revenue growth vs CYH's -1.2%
Best for: growth exposure and sleep-well-at-night
HCA
HCA Healthcare, Inc.
The Income Pick

HCA carries the broadest edge in this set and is the clearest fit for income & stability and defensive.

  • Dividend streak 5 yrs, beta 0.29, yield 0.7%
  • Beta 0.29, yield 0.7%, current ratio 0.83x
  • 9.0% margin vs CYH's -0.4%
  • Beta 0.29 vs CYH's 1.60
Best for: income & stability and defensive
THC
Tenet Healthcare Corporation
The Long-Run Compounder

THC is the clearest fit if your priority is long-term compounding and valuation efficiency.

  • 5.2% 10Y total return vs HCA's 451.4%
  • PEG 0.33 vs HCA's 0.68
  • +28.4% vs UHS's -8.1%
Best for: long-term compounding and valuation efficiency
CYH
Community Health Systems, Inc.
The Value Play

CYH is the clearest fit if your priority is value.

  • Lower P/E (0.8x vs 14.2x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthUHS logoUHS9.7% revenue growth vs CYH's -1.2%
ValueCYH logoCYHLower P/E (0.8x vs 14.2x)
Quality / MarginsHCA logoHCA9.0% margin vs CYH's -0.4%
Stability / SafetyHCA logoHCABeta 0.29 vs CYH's 1.60
DividendsHCA logoHCA0.7% yield, 5-year raise streak, vs UHS's 0.5%, (2 stocks pay no dividend)
Momentum (1Y)THC logoTHC+28.4% vs UHS's -8.1%
Efficiency (ROA)HCA logoHCA11.3% ROA vs CYH's -0.7%, ROIC 19.9% vs -70.1%

UHS vs HCA vs THC vs CYH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

UHSUniversal Health Services, Inc.
FY 2025
Acute Care Hospital Services
57.2%$9.9B
Behavioral Health Services
42.8%$7.4B
HCAHCA Healthcare, Inc.
FY 2025
Managed Care And Other Insurers
50.5%$37.0B
Managed Medicare
18.4%$13.4B
Medicare
15.4%$11.3B
Medicaid
8.1%$5.9B
Managed Medicaid
5.0%$3.7B
International
2.5%$1.9B
THCTenet Healthcare Corporation
FY 2025
Ambulatory Care
50.2%$5.2B
Hospital Operations
49.8%$5.1B
CYHCommunity Health Systems, Inc.
FY 2025
Managed Care And Other Third Party Payors
58.4%$6.0B
Medicare
21.2%$2.2B
Medicaid
19.5%$2.0B
Self Pay Revenue
0.9%$96M

UHS vs HCA vs THC vs CYH — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLTHCLAGGINGCYH

Income & Cash Flow (Last 12 Months)

THC leads this category, winning 3 of 6 comparable metrics.

HCA is the larger business by revenue, generating $75.6B annually — 4.3x UHS's $17.8B. HCA is the more profitable business, keeping 9.0% of every revenue dollar as net income compared to CYH's -0.4%.

MetricUHS logoUHSUniversal Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
RevenueTrailing 12 months$17.8B$75.6B$21.5B$21.5B
EBITDAEarnings before interest/tax$2.7B$15.5B$4.3B-$7.8B
Net IncomeAfter-tax profit$1.5B$6.8B$1.7B-$88M
Free Cash FlowCash after capex$894M$7.7B$3.3B-$200M
Gross MarginGross profit ÷ Revenue+67.6%+41.5%+42.8%+53.7%
Operating MarginEBIT ÷ Revenue+11.5%+15.8%+16.1%-39.8%
Net MarginNet income ÷ Revenue+8.6%+9.0%+7.9%-0.4%
FCF MarginFCF ÷ Revenue+5.0%+10.2%+15.6%-0.9%
Rev. Growth (YoY)Latest quarter vs prior year+9.6%+6.7%+2.8%+2.8%
EPS Growth (YoY)Latest quarter vs prior year+17.7%+44.6%+87.6%-45.2%
THC leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — UHS and CYH each lead in 3 of 7 comparable metrics.

At 0.8x trailing earnings, CYH trades at a 95% valuation discount to HCA's 15.1x P/E. Adjusting for growth (PEG ratio), THC offers better value at 0.38x vs HCA's 0.72x — a lower PEG means you pay less per unit of expected earnings growth.

MetricUHS logoUHSUniversal Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
Market CapShares × price$10.5B$96.0B$17.0B$404M
Enterprise ValueMkt cap + debt − cash$15.9B$145.2B$27.3B$11.7B
Trailing P/EPrice ÷ TTM EPS7.29x15.13x12.56x0.76x
Forward P/EPrice ÷ next-FY EPS est.7.21x14.20x10.96x
PEG RatioP/E ÷ EPS growth rate0.46x0.72x0.38x
EV / EBITDAEnterprise value multiple6.09x9.37x6.35x
Price / SalesMarket cap ÷ Revenue0.61x1.27x0.80x0.03x
Price / BookPrice ÷ Book value/share1.47x1.97x
Price / FCFMarket cap ÷ FCF12.42x12.48x6.74x1.94x
Evenly matched — UHS and CYH each lead in 3 of 7 comparable metrics.

Profitability & Efficiency

UHS leads this category, winning 5 of 9 comparable metrics.

UHS delivers a 20.7% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $20 for THC. UHS carries lower financial leverage with a 0.74x debt-to-equity ratio, signaling a more conservative balance sheet compared to THC's 1.47x. On the Piotroski fundamental quality scale (0–9), HCA scores 7/9 vs CYH's 6/9, reflecting strong financial health.

MetricUHS logoUHSUniversal Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
ROE (TTM)Return on equity+20.7%+19.6%
ROA (TTM)Return on assets+9.8%+11.3%+5.7%-0.7%
ROICReturn on invested capital+12.3%+19.9%+13.2%-70.1%
ROCEReturn on capital employed+16.0%+27.0%+13.8%-87.3%
Piotroski ScoreFundamental quality 0–96776
Debt / EquityFinancial leverage0.74x1.47x
Net DebtTotal debt minus cash$5.4B$49.2B$10.3B$11.3B
Cash & Equiv.Liquid assets$138M$1.0B$2.9B$260M
Total DebtShort + long-term debt$5.5B$50.2B$13.2B$11.6B
Interest CoverageEBIT ÷ Interest expense10.92x5.37x4.28x4.89x
UHS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

THC leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in THC five years ago would be worth $29,737 today (with dividends reinvested), compared to $2,049 for CYH. Over the past 12 months, THC leads with a +28.4% total return vs UHS's -8.1%. The 3-year compound annual growth rate (CAGR) favors THC at 40.8% vs CYH's -6.2% — a key indicator of consistent wealth creation.

MetricUHS logoUHSUniversal Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
YTD ReturnYear-to-date-23.3%-8.5%-2.5%-7.4%
1-Year ReturnPast 12 months-8.1%+21.2%+28.4%-1.0%
3-Year ReturnCumulative with dividends+19.3%+57.5%+179.1%-17.5%
5-Year ReturnCumulative with dividends+11.7%+111.1%+197.4%-79.5%
10-Year ReturnCumulative with dividends+30.4%+451.4%+519.3%-80.7%
CAGR (3Y)Annualised 3-year return+6.1%+16.4%+40.8%-6.2%
THC leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — HCA and THC each lead in 1 of 2 comparable metrics.

HCA is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than CYH's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. THC currently trades 78.7% from its 52-week high vs CYH's 64.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricUHS logoUHSUniversal Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
Beta (5Y)Sensitivity to S&P 5000.60x0.29x0.71x1.60x
52-Week HighHighest price in past year$246.33$556.52$247.21$4.47
52-Week LowLowest price in past year$152.33$330.00$146.31$2.38
% of 52W HighCurrent price vs 52-week peak+68.4%+77.2%+78.7%+64.2%
RSI (14)Momentum oscillator 0–10035.230.346.144.0
Avg Volume (50D)Average daily shares traded791K1.0M1.2M1.6M
Evenly matched — HCA and THC each lead in 1 of 2 comparable metrics.

Analyst Outlook

HCA leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: UHS as "Hold", HCA as "Buy", THC as "Buy", CYH as "Hold". Consensus price targets imply 37.8% upside for THC (target: $268) vs 2.1% for CYH (target: $3). For income investors, HCA offers the higher dividend yield at 0.69% vs UHS's 0.47%.

MetricUHS logoUHSUniversal Health …HCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …CYH logoCYHCommunity Health …
Analyst RatingConsensus buy/hold/sellHoldBuyBuyHold
Price TargetConsensus 12-month target$231.50$527.45$268.00$2.93
# AnalystsCovering analysts43463237
Dividend YieldAnnual dividend ÷ price+0.5%+0.7%
Dividend StreakConsecutive years of raises1502
Dividend / ShareAnnual DPS$0.80$2.94
Buyback YieldShare repurchases ÷ mkt cap+9.2%+10.5%+8.4%+0.5%
HCA leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

THC leads in 2 of 6 categories (Income & Cash Flow, Total Returns). UHS leads in 1 (Profitability & Efficiency). 2 tied.

Best OverallTenet Healthcare Corporation (THC)Leads 2 of 6 categories
Loading custom metrics...

UHS vs HCA vs THC vs CYH: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is UHS or HCA or THC or CYH a better buy right now?

For growth investors, Universal Health Services, Inc.

(UHS) is the stronger pick with 9. 7% revenue growth year-over-year, versus -1. 2% for Community Health Systems, Inc. (CYH). Community Health Systems, Inc. (CYH) offers the better valuation at 0. 8x trailing P/E, making it the more compelling value choice. Analysts rate HCA Healthcare, Inc. (HCA) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — UHS or HCA or THC or CYH?

On trailing P/E, Community Health Systems, Inc.

(CYH) is the cheapest at 0. 8x versus HCA Healthcare, Inc. at 15. 1x. On forward P/E, Universal Health Services, Inc. is actually cheaper at 7. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Tenet Healthcare Corporation wins at 0. 33x versus HCA Healthcare, Inc. 's 0. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — UHS or HCA or THC or CYH?

Over the past 5 years, Tenet Healthcare Corporation (THC) delivered a total return of +197.

4%, compared to -79. 5% for Community Health Systems, Inc. (CYH). Over 10 years, the gap is even starker: THC returned +519. 3% versus CYH's -80. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — UHS or HCA or THC or CYH?

By beta (market sensitivity over 5 years), HCA Healthcare, Inc.

(HCA) is the lower-risk stock at 0. 29β versus Community Health Systems, Inc. 's 1. 60β — meaning CYH is approximately 460% more volatile than HCA relative to the S&P 500. On balance sheet safety, Universal Health Services, Inc. (UHS) carries a lower debt/equity ratio of 74% versus 147% for Tenet Healthcare Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — UHS or HCA or THC or CYH?

By revenue growth (latest reported year), Universal Health Services, Inc.

(UHS) is pulling ahead at 9. 7% versus -1. 2% for Community Health Systems, Inc. (CYH). On earnings-per-share growth, the picture is similar: Community Health Systems, Inc. grew EPS 196. 7% year-over-year, compared to -52. 6% for Tenet Healthcare Corporation. Over a 3-year CAGR, UHS leads at 9. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — UHS or HCA or THC or CYH?

HCA Healthcare, Inc.

(HCA) is the more profitable company, earning 9. 0% net margin versus 4. 1% for Community Health Systems, Inc. — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: THC leads at 16. 1% versus -79. 4% for CYH. At the gross margin level — before operating expenses — UHS leads at 90. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is UHS or HCA or THC or CYH more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Tenet Healthcare Corporation (THC) is the more undervalued stock at a PEG of 0. 33x versus HCA Healthcare, Inc. 's 0. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Universal Health Services, Inc. (UHS) trades at 7. 2x forward P/E versus 14. 2x for HCA Healthcare, Inc. — 7. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for THC: 37. 8% to $268. 00.

08

Which pays a better dividend — UHS or HCA or THC or CYH?

In this comparison, HCA (0.

7% yield), UHS (0. 5% yield) pay a dividend. THC, CYH do not pay a meaningful dividend and should not be held primarily for income.

09

Is UHS or HCA or THC or CYH better for a retirement portfolio?

For long-horizon retirement investors, HCA Healthcare, Inc.

(HCA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 7% yield, +451. 4% 10Y return). Community Health Systems, Inc. (CYH) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HCA: +451. 4%, CYH: -80. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between UHS and HCA and THC and CYH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

HCA pays a dividend while UHS, THC, CYH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

UHS

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

HCA

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

THC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Stocks Like

CYH

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 142%
  • Gross Margin > 32%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform UHS and HCA and THC and CYH on the metrics below

Revenue Growth>
%
(UHS: 9.6% · HCA: 6.7%)
Net Margin>
%
(UHS: 8.6% · HCA: 9.0%)
P/E Ratio<
x
(UHS: 7.3x · HCA: 15.1x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.